Background. Malignant salivary gland tumors are rare tumors of the head and neck region. The treatment of these tumors has generally consisted of surgical extirpation, with postoperative radiotherapy improving locoregional control and survival in patients with high risk tumors. Neutron radiotherapy
Evaluation of fast neutron teletherapy for advanced carcinomas of the major salivary glands
โ Scribed by Larry W. Henry; John C. Blasko; Thomas W. Griffin; Robert G. Parker
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 452 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Undifferentiated carcinoma of the salivary glands is a rare disease, the incidence of which is highest among the inuit of greenland and north america. it was demonstrated to be closely related to epstein- barr virus (ebv) infection. however, the relation of ebv to this tumor has not
Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.
## METHODS. Clinical data and 15 histopathologic features were compared in 4 patient groups based on outcome after initial treatment. The outcome groups were 1) 2 Department of Oral and Maxillofacial Patholsurvival without disease, 2) survival with tumor recurrence only, 3) survival with ogy, Nava